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Abstract 
Background: Patients with chronic obstructive pulmonary disease (COPD) are often hospitalised with acute exacerbations 
(AECOPD) and many patients get readmitted. Intervening with hospitalised patients may be optimal timing to provide 
support. Our previous work demonstrated use of a digital monitoring and self-management support tool in the community. 
However, we wanted to explore the feasibility of recruiting patients whilst hospitalised for an AECOPD, and to identify the 
rate of dropout attrition around admission for AECOPD. 
Methods: Patients were recruited to the EDGE2 study between May 2019 and March 2020. Patients were identified by the 
clinical teams and patients were recruited by members of the clinical research team. Participants were aged 40 years or 
older, had a diagnosis of COPD and were attending or admitted to hospital for an AECOPD. Participants were given a tablet 
computer, Bluetooth-linked pulse oximeter and wrist-worn physical activity monitor to use until 6 months post-discharge. 
Use of the system aimed to support COPD self-management by enabling self-monitoring of vital signs, COPD symptoms, 
mood and physical activity, and access to multi-media educational resources. 
Results: 281 patients were identified and 126 approached. The main referral source was the specialist respiratory nursing 
and physiotherapist team (49.8% of patients identified). Twenty-six (37.1%) patients were recruited. As of 21 April 2020, 14 
(53.8%) participants withdrew and 11 (of 14; 78.6%) participants withdrew within four weeks of discharge. The remaining 
participants withdrew between one and three months follow-up (1 of 14; 7.1%) and between three and six months follow-
up (2 of 14; 14.3%). 
Conclusion: A large number of patients were screened to recruit a relatively small sample and a high rate of dropout was 
observed. It does not appear feasible to recruit patients with COPD to digital interventional studies from the hospital setting 
when they have the burden of coping with acute illness. 
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Introduction 
Patients with chronic obstructive pulmonary disease 
(COPD) are often hospitalised with acute exacerbations 
(AECOPD), presenting a mean age of 67 8 years.1 
This is a common cause of emergency admission to hos-
pital2 and costs the NHS nearly £2 billion a year.3 
Nearly half of patients are discharged within three 
days of admission4 but a quarter of patients are read-
mitted within 30 days of discharge.5 To further compli-
cate COPD management, nearly three quarters of 
patients have additional comorbidities (including coro-
nary artery disease and diabetes mellitus) and the prev-
alence of comorbid conditions increases with more 
advanced disease.6 This patient group has a high read-
mission rate, and in further testing the use of remote 
monitoring, our rationale for introducing the technolo-
gy in a hospital setting is to minimise any delay in mon-
itoring on return to the community. Prior to discharge, 
patients with COPD are administered a discharge care 
bundle as part of standard care (check inhaler technique 
and refer to appropriate services such as pulmonary 
rehabilitation and smoking cessation). Integrating a dig-
ital intervention into this existing care pathway could be 
an effective approach to prevent readmission with 
implementation as part of standard clinical pathways. 
We have previously successfully evaluated a digital 
monitoring and self-management support tool with 
COPD patients in the community.7 Our evaluation 
reported low attrition (12.7%) during the 12-month 
study and 80% using the system daily.8 We have subse-
quently moved to identifying patients admitted with 
AECOPD to hospital to evaluate linkage of data from 
hospital and the support tool. This study summarises 
the feasibility of recruiting patients whilst hospitalised 
for an AECOPD (primary aim) and identifies the extent 
to which study participants withdraw (secondary aim). 
Methods 
The sElf-management anD support proGrammE 
(EDGE2) for COPD research study was approved by 
the London-Surrey Research Ethics Committee (ref 18/ 
LO/1939) in December 2018 and prospectively regis-
tered (ISRCTN82570166). Data reported here relates 
to the 11-month recruitment period between May 2019 
and March 2020. Participants provided written 
informed consent. 
Adults visiting or admitted to the John Radcliffe 
Hospital site of the Oxford University Hospitals NHS 
Foundation Trust (OUHT), were eligible if they were 
willing and able to give informed consent, aged 40 years 
or older, had a clinical diagnosis of COPD in their 
medical records, were hospitalised because of an exac-
erbation, were a current or ex-smoker, have a post-
discharge destination that was not a medical facility 
or prison, lived in Oxfordshire or surrounding counties, 
were able to adequately understand verbal and written 
English, and were able to complete questionnaires and 
use a tablet computer. Patients were excluded if they 
had another substantial lung condition, had severe 
heart failure or had a life expectancy of less than six 
months. Clinical teams at the hospital were asked to 
identify potentially eligible patients whilst doing rou-
tine ward rounds. The clinical teams shared patients’ 
details with the clinical research team in the event the 
patient agreed they were happy to be approached about 
participating in research. The clinical research team 
then screened and enrolled patients. 
Participant details were recorded in a screening and 
enrolment log, detailing the date, referral source (which 
clinical team member), whether they were subsequently 
approached and recruited, and reasons for not being 
approached, ineligibility and non-participation. Using 
the ICD-10 codes of J44.0, J44.1 and J44.9, the total 
number of patients at the hospital for an exacerbation 
during this period was extracted from routine electron-
ic data recorded by the OUHT. 
Participants were given a tablet computer containing 
the EDGE mHealth application, a Bluetooth-linked 
pulse oximeter and wrist-worn physical activity moni-
tor. The devices were given to the participants whilst in 
hospital and participants were encouraged to use them 
up until six months post-discharge. Participants were 
given a verbal description of the system and a brief 
demonstration. Participants were encouraged to use 
the system to: 
 Self-monitor vital signs (daily 60-second acquisition 
using pulse oximeter; heart rate and oxygen satura-
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 COPD symptoms (daily questions via tablet com-
puter; participant responses about cough, breath-
lessness and use of medications collected) 
 Mood (monthly questions via tablet computer; par-
ticipant responses to mood screening questionnaires 
[PHQ-2 and GAD-2] and subsequent PHQ-8 and/or 
GAD-7 collected where the screening questionnaires 
were positive) 
 Physical activity (daily via physical activity monitor; 
step count collected). 
 Access multi-media educational resources via the 
tablet computer to support their COPD self-
management, such as videos to demonstrate correct 
inhaler technique, pulmonary rehabilitation exercises 
and self-management techniques for breathlessness. 
The occurrence, timing and reasoning for participant 
withdrawals were recorded using REDCap electronic 
data capture tools hosted at the University of Oxford.9 
Results 
Recruitment 
In total, 281 patients were identified by the clinical 
teams and 126 patients were approached (Figure 1). 
The clinical research team were most often informed 
about patients by specialist respiratory physiotherapists 
and nurses (n ¼ 140, 49.8%) whilst remaining patients 
were referred by physiotherapists (n ¼ 76, 27%), nurses 
(n ¼ 56, 19.9%), doctors (n ¼ 8, 2.8%) and other (n ¼ 1, 
0.3%). In total, 70 (55.5%) patients were eligible, of 
whom 26 (37.1%) patients were recruited. The main 
reason for ineligibility was patients lacking capacity 
(n ¼ 84, 50.9%) and the main reason for non-
participation was ‘too much going on’ (n ¼ 23, 52.3%). 
Withdrawals 
As of 21 April 2020, eight participants completed the 
study (of 26; 30.8%), four participants are still taking 
part and 14 (53.8%) participants have withdrawn. Six 
participants withdrew because they did not want to use 
the EDGE2 support tool and six participants withdrew 
because they did not feel well enough or found that 
they had “too much else going on” and the support 
tool was not manageable in parallel. Two participants 
died whilst in hospital (during the index admission and 
a re-admission). 
The 14 participants who withdrew did so at varying 
points in the study. Eleven (of 14; 78.6%) participants 
withdrew before the one-month follow up, whilst one 
Patients identified by 
clinical team n = 281 
Not approached by research team n = 155 
Reasons for non-approach: 
 Not eligible as per assessment by clinical team 
 Does not want to be part of a research project n = 29  
 Discharged before approach n = 16  
 Deceased n = 1  
Patients approached Ineligible patients n = 165 
and screened by 
clinical team n = 126 Reasons for ineligibility: 
 Unwilling or unable to provide consent n = 84  
 Had a life expectancy of six months n = 18  Not eligible n = 56  
 Post-discharge destination was a medical facility n = 16  
 Reason for hospitalisation not due to an exacerbation n = 9  
Eligible patients n = 70   Had another substantial lung condition n = 8  
 Had severe heart failure n = 7  
 Not living in Oxfordshire or surrounding counties n = 4  
 No clinical diagnosis of COPD in medical records n = 3  
 Inadequate understanding of verbal/written English n = 2  
 Not a current or ex-smoker n = 1  
 Other (incl. too unwell or visual impairment) n = 13  
Not consented n = 44  
Reasons for non-participation: 
 Too much for the patient n = 23  
 Does not want to use the tablet computer n = 13  
 Discharged before consent n = 4  
 Does not want to complete the diaries n = 1  
 Declined after family and friend involvement n = 1  
 No reason provided n = 2  
Recruited n = 26  
n =109 
Figure 1. CONSORT flow of patients screened. 
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participant withdrew between one and three months 
follow-up (of 14; 7.1%) and two participants withdrew 
between three and six months after discharge (of 14; 
14.3%). 
Discussion 
Recruiting patients hospitalised for an AECOPD to the 
EDGE2 study evaluating use of a digital health inter-
vention does not appear to be feasible. A large number 
of patients had to be screened to recruit a relatively 
small number of participants. The main concerns 
regarding the recruitment of hospitalised patients relat-
ed to the burden of illness and capacity to engage with 
self-care after discharge, with a high rate of attrition 
also recorded. 
A comparable digital intervention study recruiting 
patients hospitalised with AECOPD in the UK asked 
participants to wear a lower-back belt sitting monitor 
for two weeks after discharge. They also experienced 
low patient uptake (15.6% versus 37.1%) and a high 
proportion of participant withdrawals (48.5% versus 
53.8%).10 Ineligibility reasons largely related to feeling 
too unwell (40%) and too severe comorbidities 
(36.4%). Common reasons for withdrawal related to 
feeling unwell and overwhelmed after experiencing an 
exacerbation (having lots of hospital appointments, 
readmissions, dealing with other comorbidities, medi-
cations and lack of social support). A trial of the 
MyCOPD app in patients recently hospitalised with 
COPD found that of the 124 potentially eligible 
patients, more than half declined study inclusion with-
out giving a reason and recorded a 15% withdrawal 
rate.11 Another study enrolled patients with COPD 
whilst hospitalised but this time to a non-digital sup-
ported self-management programme (“SPACE For 
COPD).12 They revealed that 35.3% of approached 
patients declined participation in the study without 
reason, with others deciding not to participate due to 
comorbidities, mental health problems and being 
unable to read/see. In comparison to the present 
study, their withdrawal rate was much lower at 
10.3%. A web-based version of that study (instead 
offering information on a tablet or PC) reported 
more than two thousand patients were screened to 
reach 100 participants (4.8% of patients screened). 
Predominate reasons for exclusion reported were not 
being web literate (69%), unwilling (15%) or had 
comorbidities precluding involvement (12%).13 Our 
study findings that recruiting patients with COPD 
during hospitalisation can be difficult appear to be 
supported by the literature. 
Previous work in which the original EDGE system 
was evaluated with patients in the community demon-
strated that patients were able to use the application, 
interpret clinical data, and use these within their self-
management approach regardless of previous knowl-
edge.8 The intervention development process focused 
on the provision of a simple and intuitive application 
that could be used - and which was used - regardless of 
participants’ previous computer experience or self-
reported digital literacy. No changes have been made 
to the intervention components or delivery between 
that proof-of-concept study and the current work. It 
is therefore reasonable to assume that attrition in the 
current study can be explained more by implementa-
tion processes than by limitations in the intervention 
itself. The distinction between the introduction of an 
intervention in the community versus introduction 
during a hospital admission is likely to be a critical 
factor in the implementation process. Timing of intro-
ducing interventions around hospitalisation is impor-
tant in this vulnerable patient group. It is possible that 
interventions that focus on non-intrusive monitoring 
by health care staff may be acceptable. But where 
patients need to make measurements or engage in 
self-management, the acute hospital may be a subopti-
mal setting to start a digital intervention. 
Consideration needs to be given to the timing of 
introducing an intervention and balancing this against 
the burden of coping with acute illness. There is a risk 
that, if digital tools to support self-management were 
to be introduced into acute care settings, vulnerable 
patients could potentially be overburdened at a time 
when their illness was imposing great physical and psy-
chosocial stress. 
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